baber/WOPTO huggingface dataset:
Patent MX-162643-A (MX)
Inventor: ERPENBACH HEINZ
IPC: C07C67/48
Filed: 1982-09-22
Abstract: 1. Process for recovering iodine compounds from the off-gas originating from the reaction of methyl acetate and/or dimethylether with carbon monoxide and optionally hydrogen to acetic anhydride and optionally ethylidene diacetate in the presence of a catalyst system consisting of carbonyl complexes of noble metals of group VIII of the Periodic System, an iodine compound, acetic acid, an organophosphorus or organonitrogen compound and, optionally, carbonyl-yielding compounds of common metals, wherein the off-gas removed together with the liquid reaction products is wholly or partially subjected to countercurrent scrubbing treatment with methyl acetate at temperatures of - 40 degrees C up to + 20 degrees C.
Patent MX-161572-A (MX)
Inventor: HONEY STANLEY K
IPC: G08G1/0969
Filed: 1985-06-06
Abstract: A vehicle navigational system and method for tracking a vehicle, including a programmed computer (12), sensors for sensing the distance (18) traveled and heading (28) of the vehicle, and a stored map data base (14) identifying a map of an area over which the vehicle is moving, in which the computer calculates and advances dead reckoned positions of the vehicle in response to distance and heading data, provides data identifying a contour of equal probability containing the dead reckoned positions and having a probability of containing the actual location of the vehicle, derives multiparameters from the map data base, and updates a given dead reckoned position and the contour using a highly developed vehicle navigational algorithm if a more probable dead reckoned position exists based upon the given dead reckoned position, the contour and the derived multi-parameters.
Patent NZ-198892-A (NZ)
Title: Continuous butt welding
Inventor: HUME K M
IPC: B23K9/02
Filed: 1981-11-06
Abstract: There is disclosed a method of butt welding of flat steel plate or steel pipe seams by a submerged arc process in which weld metal is deposited in the weld gap from one side only including the steps of applying powdered flux (21) to the weld gap, compacting the flux by a support device (10) and a conveyor (12) and maintaining the flux in position whilst weld material is applied to the weld gap.
Patent NZ-202391-A (NZ)
Title: 1-furyl-3,4-dihydroisoquinolines and pharmaceutical compositions containing such
Inventor: LOSEL W
IPC: C07D405/04
Filed: 1982-11-04
Abstract: Compounds of the formula   <IMAGE>   wherein R1 and R2, which may be identical to or different from each other, are each hydroxyl or lower alkoxy R3 is cyano or -CO-Y; Y is hydroxyl, lower alkoxy, or a primary or secondary, substituted or unsubstituted, aliphatic, cycloaliphatic, araliphatic, aromatic or heterocyclic amino group; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful for the treatment of circulatory and coronary disorders.
Patent NZ-212999-A (NZ)
Title: Entangled non woven fabric; fusible fibres at one surface thermobonded to base fibres
Inventor: MAYS A T
IPC: D04H1/54
Filed: 1985-08-05
Abstract: There is disclosed an entangled nonwoven fabric having a layer of fusible fibers on one or both surfaces of a relatively thick layer of base fibers. The fusible fibers are either homofil or conjugate fibers having an exposed low melting point component which have a lower melting temperature than the base fibers. The thermoplastic fibers are located on the outer surface of the base fibers either prior to or subsequent to the entangling of the fibers. The mixture of base and thermoplastic fibers are then heated to a temperature to heat fuse the homofil fibers or the low melting point component of the conjugate fibers.
Patent NZ-222433-A (NZ)
Title: Small-particle aerosols containing liposomes
Inventor: KNIGHT JACK VERNON
IPC: A61K9/72
Filed: 1987-11-03
Abstract: Disclosed are small particle aerosol liposome and liposome-drug combinations advantageous for the treatment of a wide variety of diseases. Different methods of preparation of liposome and liposome-drug combinations are described which can be used in small particle aerosol treatment.
Patent NZ-223800-A (NZ)
Title: Process for production of an isobutylbenzene from an isobutenylcyclohexene
Inventor: KENT A G
IPC: C07C5/48
Filed: 1988-03-08
Abstract: An isobutylbenzene (IBB) is produced from an isobutenylcyclohexene (IBCH) by contacting at elevated temperature the IBCH in the presence of a molecular oxygen-containing gas with a catalyst comprising a supported transition metal in the form of the elemental metal and/or a compound thereof, for example palladium supported on alumina.
Patent NZ-230178-A (NZ)
Title: Apparatus for forming internally plastics coated metal tubing
Inventor: BARNOACH ITZHAK
IPC: B29C48/153
Filed: 1989-08-02
Abstract: Apparatus for forming a plastics coated metal tube comprising means for forming a continuous strip of metal into a U-shape and a forming sleeve for folding the strip into an overlapping tube. A mandrel (23) is also provided which extends through the forming sleeve and through a locating sleeve (30). The locating sleeve (30) centralises the tube as it passes over the mandrel and welding means are provided for welding the overlapping tube as it passes through the locating sleeve (30). According to the invention, the welding means comprises an ultrasonic welding wheel (32) and drive means for the welding wheel, the drive means being capable of driving the welding wheel (32) at a peripheral speed identical to the speed at which the overlapping tube is drawn past the wheel.
Patent NZ-232832-A (NZ)
Title: Cdna encoding the beta-chain of an il-2 receptor
Inventor: TADATSUGU TANIGUCHI
IPC: C12N1/00
Filed: 1990-03-07
Abstract: Recombinant IL-21R beta  chain or portions thereof, cDNA coding therefore, vectors containing said cDNA, hosts transfected by said vectors, and monoclonal antibodies to said recombinant IL-2R beta  or portions thereof.
Patent NZ-245674-A (NZ)
Title: Imidazole derivatives and anti-hiv medicaments
Inventor: SUGIMOTO HIROHIKO
IPC: C07D233/54
Filed: 1993-01-13
Abstract: A novel imidazole derivatives of formula I: <CHEM> wherein R<1> is hydrogen, alkyl, halogen, or optionally substituted aryl; R<2> is alkyl, optionally substituted aryl optionally substituted aralkyl, or optionally substituted hetero ring group; R<3> is hydrogen, alkyl, optionally substituted aryl, optionally substituted aralkyl, or optionally substituted hydroxyalkyl; R<4> is hydrogen, alkyl, halogen, acyl, optionally substituted hydroxyalkyl, optionally esterified or amidated carboxyl group, hydroxy group, aryl or arylthio; X is S, SO, SO2, CH2, or Se; n is an integer of 1 to 3, or a pharmaceutically acceptable salt thereof, said derivative having anti-HIV activity and being useful for the treatment of HIV infections.
Patent NZ-252598-A (NZ)
Title: Device for the transdermal administration of oxybutynin (or salts thereof) comprising a backing material, drug reservoir having a permeation enhancer and means of contact with the skin
Inventor: LEE EUN SOO
IPC: A61K47/34
Filed: 1993-05-13
Abstract: The present invention is directed to the transdermal administration of oxybutynin together with a suitable permeation enhancer. The invention includes a transdermal drug delivery device comprising a matrix adapted to be placed in oxybutynin- and permeation enhancer-transmitting relation with the skin site. The matrix contains sufficient amounts of a permeation enhancer and of oxybutynin, in combination, to continuously administer to the skin for a predetermined period of time the oxybutynin to provide an effective therapeutic result. The invention is also directed to a method for the transdermal administration of a therapeutically effective amount of oxybutynin together with a skin permeation-enhancing amount of a suitable permeation enhancer.
Patent NZ-253431-A (NZ)
Title: Catalysts for the production of carbon fibrils; fibrils and catalysts therefrom
Inventor: MOY DAVID
IPC: B01J31/18
Filed: 1993-05-12
Abstract: An improved catalyst for producing carbon fibrils is made by incorporating an effective yield-enhancing amount of a carboxylate into a fibril-forming catalyst. Alternatively, such a catalyst is made by coprecipitating a compound of a metal having fibril-forming catalytic properties and an aluminum and/or magnesium compound, optionally in the presence of carbon particles or carbon fibril aggregates. The catalyst may also be made by incorporating a compound of a fibril-forming metal onto magnesia particles in carbon particles or carbon fibril aggregates. The catalysts, methods of using them to form carbon fibrils and those carbon fibrils are also disclosed.
Patent NZ-270298-A (NZ)
Title: Conditioning press felts for deinked recycled newsprint papermaking systems
Inventor: KHAN ABDUL QAVI
IPC: D21H21/24
Filed: 1995-01-06
Abstract: A method is disclosed for conditioning the felts in a papermaking process utilizing deinked secondary fiber in the furnish by adding a felt conditioner consisting of from 5-33% of a nonionic surfactant, from 5-33% of a dispersant, or blends thereof, with the remainder water; wherein the nonionic surfactant is selected from the group consisting of ethoxylated nonylphenols having moles of ethoxylation of from 7.5 to 30 and an HLB of about 12 to 17.2 and di-alkyl phenol ethoxylates having moles of ethoxylation of from 15 to 24 and an HLB of about 13 to 15.1; and wherein the dispersant is selected from the group consisting of the sodium salt of naphthalene sulfonate formaldehyde-condensate having an average molecular weight of from about 700 to 3500, the potassium salt of polymerized alkyl naphthalene sulfonic acid having an average molecular weight of approximately 1000, or the sodium or ammonium salt of lingosulfonate. Additionally, and optionally, from 1 to 5% of an alkylether hydroxypropyl sultaine may be added to enhance performance.
Patent NZ-282824-A (NZ)
Title: Contraceptive preparation; two hormonal components packaged separately for sequential administration; first hormone being estrogen and gestagen and a second hormone being estrogen.
Inventor: LACHNIT URSULA
IPC: A61K31/565
Filed: 1995-03-30
Abstract: PCT No. PCT/EP95/01190 Sec. 371 Date Dec. 16, 1996 Sec. 102(e) Date Dec. 16, 1996 PCT Filed Mar. 30, 1995 PCT Pub. No. WO95/26730 PCT Pub. Date Oct. 12, 1995A pharmaceutical combination preparation with two hormone components that are manufactured physically separately in a packaging unit and that are intended for time-sequential oral administration, which in each case consist of a number of daily dosage units that are placed physically separately and are individually removable in the packaging unit. As a hormonal active ingredient, a first hormone component contains in combination an estrogen preparation and, in at least a dosage that is sufficient to inhibit ovulation, a gestagen preparation, and as a hormonal active ingredient the second hormone component contains only an estrogen preparation. The first hormone component comprises 23 or 24 daily units and the second hormone component comprises 4 to 10 daily units. The total number of hormone daily units is equal to the total number of days of the desired cycle, but at least 28 days in length. This combination preparation is used for female birth control, and allows for an estrogen content that is as low as possible in each individual dosage unit and also has a low total hormone content per administration cycle, with high contraceptive reliability, low incidence of follicular development, and satisfactory cycle control, with reliable avoidance of intracyclic menstrual bleeding as well as of undesirable side-effects.\!
Patent NZ-287604-A (NZ)
Title: Acylated enol derivatives as prodrugs of elastase inhibitors
Inventor: PEET NORTON PAUL
IPC: C07K5/08
Filed: 1995-05-08
Abstract: This invention relates to acylated enol derivatives of known elastase inhibitors. These compounds are useful in the treatment of various inflammatory diseases, including cystic fibrosis and emphysema or as prodrugs of compounds which are useful in the treatment of said diseases.
Patent NZ-295711-A (NZ)
Title: Thick film element for immersion heater accommodates temperature sensor
Inventor: LITTLE PETER JAMES
IPC: H05B3/74
Filed: 1995-11-27
Abstract: PCT No. PCT/GB95/02750 Sec. 371 Date May 9, 1997 Sec. 102(e) Date May 9, 1997 PCT Filed Nov. 27, 1995 PCT Pub. No. WO96/17497 PCT Pub. Date Jun. 6, 1996A thick film resistive heating element having a thick film resistive track applied to the surface of an electrically insulative substrate. An encapsulating insulating layer is applied over the track to protect it while an area of the element is left uncovered by the encapsulating layer so as to define a window. A portion of a temperature sensitive control device is then placed in direct contact with the track and/or the electrically insulative substrate through the window. The window in the element is located in that area of the element which will be uncovered by the liquid prior to the rest of the element as the liquid boils away or is evacatuated from the vessel.
Patent NZ-297072-A (NZ)
Title: Cross-linked micro-particles which are hydrophillic and capable of reconstitution in water; use as therapeutic vehicles
Inventor: SUTTON ANDREW DEREK
IPC: A61K9/107
Filed: 1995-12-14
Abstract: A sterile powder comprising microparticles, 0.1 to 50  mu m in diameter, obtainable by spray-drying and cross-linking a water-soluble material having free functional groups, is characterised in that the microparticles are hydrophilic, can be reconstituted in water to give a monodisperse suspension, and have retained said groups available for derivatisation. The particles are linked to drugs or other functional molecules, and used as vehicles in therapy.
Patent NZ-309659-A (NZ)
Title: Composition comprising LbeIF4A and/or LmeIF4A polypeptides (Leishmania antigen) and methods for enhancing immune responses
Inventor: REED STEVEN G
IPC: A61K38/00
Filed: 1996-06-05
Abstract: ethods for eliciting or enhancing immune responses to Leishmania antigens (LbeIF4A or LmeIF4A) , including tumor antigens, and/or DNA vaccines are provided. The methods employ polypeptides or nucleic acid compositions that contain at least a biologically active portion of a Leishmania braziliensis or Leishmania major homologue of the eukaryotic initiation factor 4A (eIF4A), or a variant thereof. Such polypeptides and compositions are useful for enhancing or eliciting a patient's cellular and/or humoral immune response, for instance within methods for treating tumors.
Patent NZ-332018-A (NZ)
Title: Acidic polylactic polymers comprising lactate, glycolic, and tartaric acid units
Inventor: LOUGHMAN THOMAS CIARSN
IPC: C08G63/60
Filed: 1998-10-07
Abstract: A biodegradable polyester comprising lactic acid, glycolic acid units and at least one hydroxy-polycarboxylic acid unit (i.e., one or more units, such as tartaric acid, pamoic, or an ester thereof. The polyester contains 4-100 carboxyl groups and has an average molecular weight of 1,000 to 200,000 g/mol. The method provided includes a process of increasing free carboxyl groups of the biodegradable polyester.
Patent NZ-333577-A (NZ)
Title: Polynucleotides and fragments thereof of lysyl oxidase
Inventor: WEISS ANTHONY STEVEN
IPC: A61P17/02
Filed: 1997-08-11
Abstract: Polynucleotides that encode lysyl oxidase and have a CAI score of at least 0.30 in E. coli. These nucleotides encode amino acid sequences capable of catalysing the oxidation of primary amines. These polynucleotides permit the expression of functional lysyl oxidase, lysyl oxidase like molecules or variants of these species in plants.
Patent NZ-334400-A (NZ)
Title: Method, instruments and kit for autologous transplantation comprising hemostatic barrier and a covering patch
Inventor: VIBE-HANSEN HENRIK
IPC: A61L27/00
Filed: 1997-08-29
Abstract: A method for the effective transplantation of chondrocytes/cartilage (3) to an articular joint surface defect. Disclosed is a method of preparing a graft site and the autologous transplantation of cells to the prepared graft site. The chondrocytes are prepared in a suitable matrix and grafted to a surface to be treated. A homeostatic barrier (1) is placed within the defect in the cartilage cap to inhibit or prevent the penetration of vascularising cells and tissue into the regenerating cartilage, but is still able to provide nutrients to the grafted chondrocytes held within. A cell-free covering patch (2) is used to form a cap/patch or bandage over the defect site. The method provides for a site for which the desired mesenchymal specialised chondrocytes are formed for the prevention of arthritic pathologies.
Patent NZ-334604-A (NZ)
Title: A DNA molecule containing a baculovirus promoter operable linked to a coding sequnce for an insect-specific toxin; biological insect control agents comprising the altered baculovirus
Inventor: MILLER LOIS
IPC: A01N63/50
Filed: 1997-10-01
Abstract: A recombinant DNA molecule is claimed comprising: a)	a promoter selected from the group consisting of a baculovirus 6.9K promoter, a baculovirus DA26 promoter and a heat shock gene promoter and b)	a coding sequence for an insect-specific toxin. The coding sequence is operable linked to and expressed under the regulatory control of the promoter. A baculovirus containing the above DNA molecule is also claimed.
Patent NZ-337136-A (NZ)
Title: Implement for automatically milking animals comprising two cameras attached to a robot arm
Inventor: FRANSEN RENE
IPC: A01J5/02
Filed: 1997-07-21
Abstract: An implement for automatically milking animals such as cows is provided with a milking robot including a robot arm (14), which is adapted to carry teat cups (21).  The robot arm also has two cameras (22), which are fixedly arranged at different angles.
Patent NZ-501266-A (NZ)
Title: Cyanoguanidines as cell proliferation inhibitors
Inventor: SCHOU CHARLOTTE
IPC: A61K31/44
Filed: 1998-05-15
Abstract: A compound of the formula I, wherein: the attachment to the pyridine ring is in the 3- or 4-position; R is one or more substituents independently selected from hydrogen, halogen, trifluoromethyl, carboxy, alkyl, alkoxy, alkoxycarbonyl, nitro, amino and cyano; Q is a straight, branched, cyclic, saturated or unsaturated divalent hydrocarbon radical; X is carboxy, amino, tetrahydropyranyloxy, saturated or unsaturated alkoxycarbonylamino, alkoxycarbonyl or di(alkoxy)phosphinoyloxy. The compounds are useful for the treatment or prophylaxis of diseases characterised by undesirable cell proliferation, particularly skin cells or cancer cells.
Patent NZ-504070-A (NZ)
Title: Triangular spa with two seats
Inventor: LARSEN CHRISTOPHER
IPC: A61H33/00
Filed: 2000-04-18
Abstract: A portable spa comprising:  a) First, second and third outer wall segments, the first segment forming at one end into a first end of the second segment and at an opposite end into a first end of the third segment, a second end of the second segment forming into a second end of the third segment, thereby forming a continuous three-sided outer wall; and b) First and second adjacent seating areas disposed at an acute angle to one another, said first and second seating areas lying within said outer wall and constituting the only seating areas formed in said spa.
Patent NZ-505082-A (NZ)
Title: A phospholipid suspension containing a lipid blend useful as an ultrasound contrast agent
Inventor: HUI POH K
IPC: A61K9/127
Filed: 1999-01-14
Abstract: A process for preparing a phospholipid suspension comprises: a) contacting at least two lipids with a first non aqueous solvent (such as a mixture of methanol and toluene)  to form a solution; b)concentrating the solution to a thick gel; c) contacting the gel with a second non-aqueous solvent (such as methyl t-butyl ether) to form a solution; d) concentrating the solution of step c) to form a lipid blend; e) contacting the lipid blend with a third non-aqueous solvent (such as propylene glycol, ethylene glycol or polyethylene glycol 300) whereby the lipid blend substantially dissolves in the third non-aqueous solvent to form a solution and f) without removing the third non-aqueous solvent, contacting the solution from step e) with an aqueous solution to form a phospholipid suspension. The lipid blend can comprise 1,2-dipalmitoyl-sn-glycero-3-phosphatidylcholine; 1,2-dipalmitoyl-sn-glycero-3-phosphotidic, mono sodium salt and N-(methoxypolyethylene glycol 5000 carbamoyl)-1,2-dipalmitoyl-sn-glycero-3-phosphatidylethanolamine, mono sodium salt. The phospholipid suspension of step f) can be further heated to a temperature equal to or above the highest gel to liquid crystalline phase transition temperature of the lipids present in the suspension, then filtered through a sterilizing filter and dispensed into a vial.  The headspace gas of the vial can be exchanged with a perfluorocarbon gas. The suspension is useful as an ultrasound contrast agent.
Patent NZ-507435-A (NZ)
Title: Novel polypeptides and nucleic acids with homology to cornichon
Inventor: YUAN JEAN
IPC: C07K16/40
Filed: 1999-03-08
Abstract: A nucleic acid has at least 80 % sequence identity to a nucleotide sequence that encodes a polypeptide comprising the amino acid sequence shown in Figure 129 (SEQ ID NO:322). Preferably the nucleic acid has the sequence shown in Figure 128 (SEQ ID NO:321) or comprises the full coding sequence of the DNA deposited under accession number ATCC 209775. Also described are vectors and non-human host cells comprising the nucleic acids and antibodies directed against the polypeptide, methods of producing the polypeptide and compositions comprising the antibody.
Patent NZ-508405-A (NZ)
Title: Electronic commerce application with multiple shopping carts for user, each with a different user setting
Inventor: SPIEGEL JOEL R
IPC: G06Q30/06
Filed: 1999-06-25
Abstract: The system provides multiple electronic shopping carts (101) for each user in an electronic commerce environment. Each electronic shopping cart has an indication of items currently within the electronic shopping cart (102) and billing and shipment information (103c). The system generates a display that identifies each of the electronic shopping carts and sends the generated display to a user computer system. The system then receives a selection of one of the identified electronic shopping carts from the user computer system and receives a selection of an item from the user computer system. In response to receiving the selection of the item, the system adds the item to the selected electronic shopping cart (103a). The system then receives an indication to checkout the items in the selected electronic shopping cart from the user computer system. In response to receiving the indication to checkout, the system ships the items in the selected electronic shopping cart in accordance with the shipment information of the selected electronic shopping cart and bills for the items in the selected electronic shopping cart in accordance with the billing information for the selected electronic shopping cart. The system thus allows a user to select each of the electronic shopping carts for adding items to each electronic shopping cart.
Patent NZ-508794-A (NZ)
Title: Pivoting motorcycle frame enabling rear driving wheel to remain vertical
Inventor: KEIR NORMAN HAROLD
IPC: B62D12/00
Filed: 2000-12-12
Abstract: A two piece pivoted frame for a motor cycle having two wheels comprising a rear sprung sub-frame (1) attached to the front frame section (2) of the motor cycle via a half raced joint below the riders seat and an instant control mechanism to control the pivoting movement of the sub-frame to be operated by the rider.